Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bristol-Myers Squibb CEO insists proposed Celgene purchase not a "defensive deal"

firstwordpharmaMarch 13, 2019

Tag: Bristol-Myers Squibb , Celgene , defensive deal

PharmaSources Customer Service